After Nu Skin (NUS) announced the sale of its marketing tech platform business, Mavely, to Summit Partners portfolio company Later, Jefferies noted that this transaction generated about a five-times return on company’s investment in Mavely since the acquisition in 2021. Nu Skin’s Q3 sales softness was offset by strength from the Rhyz business, with strength led by Mavely, noted the analyst, who also points out that the company will have a minority stake in the Later and Mavely combined businesses. Jefferies has a Hold rating and $7 price target on Nu Skin shares.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NUS:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue